Treatment outcomes of reduced-dose ganciclovir injectio

Not Applicable

Completed

• Conditions: CMVR lesionvisual acuityintraocular pressure; cytomegalovirus retinitis; ganciclovir; intravitreal injections; treatment outcomes

• Registration Number: TCTR20160316001
• Lead Sponsor: Siriraj Development Research Fund (managed by Routine to Research:R2R)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2012-09-16
• Study Start: 2016-03-16
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Patients with cytomegalovirus retinitis

Exclusion Criteria

patients with concomitant retinal inflammation
patients who previously treated with ganciclovir

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Resolution of CMVR lesion 24 weeks after medication Indirect ophthalmoscopic examination

Secondary Outcome Measures

Name	Time	Method
change of visual acuity at resolution of lesion snellen visual acuity,incidence of complication during treatment clinical observation